H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Stock Down 0.0 %
The company has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32. The firm’s 50 day simple moving average is $22.00 and its 200-day simple moving average is $22.00.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Articles
- Five stocks we like better than H. Lundbeck A/S
- Basic Materials Stocks Investing
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- 3 Warren Buffett Stocks to Buy Now
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- What Makes a Stock a Good Dividend Stock?
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
